Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer: A tentative quantitative evaluation of organ preservation and clinical response

International Journal of Oncology

Volumn 9, Issue 3, 1996, Pages 571-578

  Mantovani, Giovanni ^a   Gebbia, Vittorio ^b   Proto, Ernesto ^a   Cossu, Francesco ^a   Bianchi, Alessandro ^a   Curreli, Luigi ^a   Ghiani, Massimo ^a   Astara, Giorgio ^a   Lampis, Biancarosa ^a   Dessi, Daniela ^a   Santona, Maria Cristina ^a   Massa, Elena ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

clinical response; combined modality therapy; neo adjuvant chemotherapy; oral cavity and oropharynx cancer (advanced stage); organ function preservation

Indexed keywords

CISPLATIN; FLUOROURACIL; MANNITOL; NAVELBINE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUTH CANCER; NEPHROTOXICITY; ORGAN PRESERVATION; OROPHARYNX CANCER; PRIORITY JOURNAL; SCORING SYSTEM; SURGICAL APPROACH; TREATMENT OUTCOME; TREATMENT PLANNING; WEIGHT REDUCTION;

EID: 0029787262     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Dimery IW and Hong WK: Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 85: 95-111, 1993.
2. Skoog LA and Vokes EE: Chemotherapy, biologics, and chemoprevention as systemic therapies for head and neck. Curr Opin Oncol 6: 277-284, 1994.
3. Vokes EE and Athanasiadis I: Chemotherapy for squamous cell carcinoma of head and neck. Ann Oncol 7: 15-29, 1996.
4. Al-Sarraf M: Head and neck cancer: chemotherapy concepts. Semin Oncol 15: 70-85, 1988.
5. Gebbia V, Zerillo G, Gebbia N, et al: Chemotherapy in head and neck cancer (I): management of recurrent or metastatic disease. J Chemotherapy 4: 244-259, 1992.
6. Choksi AJ, Dimery IW and Hong WK: Adjuvant chemotherapy of head and neck cancer; the past, the present, the future. Semin Oncol 15: 45-59, 1988.
7. Jacobs C, Goffinet DR, Goffinet L, et al: Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer: a report from the Northern California Oncology Group. Cancer 69: 1178-1183, 1987.
8. Fazekas JT, Sommer C and Kramer S: Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancer of the oral cavity, oropharynx, supraglottic larynx or hypopharynx. Int J Radiat Oncol Biol Phys 6: 533-541, 1980.
9. Stell PM, Dalby JE, Strickland P, et al: Sequential chemotherapy and radiotherapy in advanced head and neck cancer. Clin Radiol 34: 463-467, 1983.
10. Taylor SGIV, Applebaum E and Showel JL: A randomized trial of adjuvant chemotherapy in head and neck cancer. J Clin Oncol 3: 672-679, 1985.
11. Kun LE, Toohill R, Holoye PY, et al: A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 12: 173-178, 1986.
12. Head and Neck Contracts Program: Adjuvant chemotherapy for advanced head and neck squamous carcinoma: final report. Cancer 60: 301-311, 1987.
13. Schuller DE, Metch B, Stein DW, Mattox D and McCraken JD: Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope 98: 1205-1211, 1988.
14. Jacobs C and Makuch R: Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the head and neck contracts program. J Clin Oncol 8: 838-847, 1990.
15. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324: 1685-1690, 1991.
16. Forastiere AA: Randomized trials of induction chemotherapy. A critical review. Hematol Oncol Clin N Amer 5: 725-736, 1991.
17. Forastiere AA: Cisplatin and radiotherapy in the management of locally advanced head and neck cancer. Int J Biol Phys 27: 465-470, 1993.
18. Laramore GE, Scott C, Al-Sarraf M, et al: Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report of intergroup study 0034. Int J Radiat Oncol Biol Phys 23: 705-713, 1992.
19. Jaulerry C, Rodriguez J, Brunin F, et al: Induction chemotherapy in advanced head and neck tumors: results of two randomized trials. Int J Radiat Oncol Biol Phys 23: 483-489, 1992.
20. Vokes EE, Haraf DJ, Weichselbaum RR and Brachman D: Induction chemotherapy: promises and limitations. In: Head and Neck Cancer. Vol. 3. Johnson JT and Didolkar MS (eds). Excerpta Medica Int. Congress Series 1009, pp321-326, 1993.
21. Paccagnella A, Orlando A, Marchiori C, et al: Phase II trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86: 265-272, 1994.
22. Browman GP: Evidence-based recommendations against neo-adjuvant chemotherapy for routine management of patients with squamous cell head and neck cancer. Cancer Invest 12: 662-671, 1994.
23. Pfister DG, Strong E, Harrison L, et al: Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 9: 850-859, 1991.
24. Urba SG, Forastiere AA, Wolf GT, et al: Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. J Clin Oncol 12: 946-953, 1994.
25. Clayman GL, Weber RS, Guillamondegui O, et al: Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers. Arch Otolaryngol Head Neck Surg 121: 219-223, 1995.
26. Taylor SG, Murthy AK, Caldarelli DD, et al: Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer. J Clin Oncol 7: 846-856, 1989.
27. Karp DD, Vaughan CW, Carter R, et al: Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report. Amer J Clin Oncol 14: 273-279, 1991.
28. Pfister DG, Harrison LB, Elliot W, et al: Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation. J Clin Oncol 13: 671-680, 1995.
29. International Union Against Cancer: TNM-Classification of Malignant Tumors. 3rd edition. UICC, Geneva, 1978.
30. Gebbia V, Mantovani G, Agostara B, et al: Treatment of recurrent metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: a multicenter phase II trial. Ann Oncol 6: 987-991, 1995.
31. Gebbia V, Testa A, Valenza R, et al: A pilot study of vinorelbine on a weekly schedule in recurrent and or metaslatic squamous cell carcinoma of the head and neck. Eur J Cancer 29A: 1358-1359, 1994.
32. Miller AB, Hodgstraten B, Staquet M and Winkler A: Reporting results of cancer treatment. Cancer 47: 207-214, 1981.
33. List MA, Ritter-Sterr C and Lansky SB: A performance status scale for head and neck cancer patients. Cancer 66: 564-569, 1990.
34. Wening BL: The role of surgery in head and neck cancer: standard care and new horizons. Semin Oncol 21: 289-295, 1994.
35. Sweeney PJ, Haraf DJ, Vokes EE, Dougherty M and Weichselbaum RR: Radiation therapy in head and neck cancer: indications and limitations. Semin Oncol 21: 296-303, 1994.
36. Whicker JH, Desanto LW and Divine KD: Surgical treatment of squamous cell carcinoma of the base of tongue. Laryngoscope 82: 1853-1860, 1972.
37. DuPont JB, Guillamondegui OM and Jesse RH: Surgical treatment of advanced carcinomas of the base of tongue. Am J Surg 136: 501-503, 1978.
38. Parsons JT, Million RR and Cassisi NJ: Carcinoma of the base of tongue: results of radical irradiation with surgery reserved for radiation failure. Laryngoscope 92: 689-696, 1982.
39. Marcial VA, Hanley JA, Hendrickson F, et al: Split-course radiation therapy of carcinoma of the base of tongue: results of a prospective national collaborative clinical trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 9: 437-443, 1983.
40. Thawley SE, Simpson JR, Perez CA, et al: Preoperative irradiation and surgery for carcinoma of the base of tongue. Ann Otol Rhinol Laryngol 92: 485-490, 1983.
41. Gallery CD, Spiro RH and Strong EW: Changing management of squamous carcinoma of the tongue. Am J Surg 148: 449-454, 1984.
42. 192Ir pharyngoepiglottic fold implants: the key to successful treatment of base tongue carcinoma by radiation therapy. Cancer 55: 941-948, 1985.
43. l92iridium irradiation in the treatment of carcinoma of the base of tongue: a ten-year experience. Int J Radiat Oncol Biol Phys 14: 839-848, 1988.
44. Harrison LB, Zelefsky M, Sessions RB, et al: Base-of-tongue cancer treated with external beam irradiation plus brachytherapy: oncologic and functional outcome. Radiology 184: 267-270, 1992.
45. Kraus DH, Vastola AP, Huvos AG, et al: Surgical treatment of squamous cell carcinoma of the base of tongue. Am J Surg 166: 384-388, 1993.
46. Rooney M, Kish J, Jacobs J, et al: Improved complete response rate and survival in advanced head and neck cancer after three course induction chemotherapy with 120 h 5-FU infusion and cisplatin. Cancer 55: 1123-1128, 1985.
47. Al-Kourainy K, Kish J, Ensley J, et al: Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer 59: 233-238, 1987.
48. Ervin TJ, Clark JR, Weichselbaum RR, et al: An analysis of induction and adjuvant chemotherapy in the multidisciplinary management of squamous cell carcinoma of the head and neck. J Clin Oncol 5: 10-20, 1987.
49. Bosl GJ, Strong E, Harrison L and Pfister DG: Chemotherapy and the management of locally advanced squamous cell carcinoma of the head and neck: role in larynx preservation. In: Important Advances in Oncology. DeVita VT Jr, Hellman S and Rosenberg SA (eds). Lippincott, Philadelphia, pp191-203, 1991.
50. Pfister DG, Harrison LB, Strong EW, et al: Current status of larynx preservation with multimodality therapy. Oncology 6: 33-43, 1992.